Molecular Oncology
Volume 3, Issue 4 , Pages 366-375, August 2009

Autophagy in tumour suppression and promotion

  • Andreas Brech

      Affiliations

    • Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, N-0310 Oslo, Norway
    • Department of Biochemistry, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway
  • ,
  • Terje Ahlquist

      Affiliations

    • Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, N-0310 Oslo, Norway
    • Department of Cancer Prevention, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway
  • ,
  • Ragnhild A. Lothe

      Affiliations

    • Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, N-0310 Oslo, Norway
    • Department of Cancer Prevention, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway
  • ,
  • Harald Stenmark

      Affiliations

    • Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Montebello, N-0310 Oslo, Norway
    • Department of Biochemistry, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Department of Biochemistry, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Montebello, N-0310 Oslo, Norway. Tel.: +47 22934951; fax: +47 22508692.

Received 5 May 2009; accepted 27 May 2009. published online 18 June 2009.

Abstract 

Autophagy, a well-described cellular mechanism for lysosomal degradation of cytoplasmic content, has emerged as a tumour suppression pathway. Recent evidence indicates that the tumour suppressor function of autophagy is mediated by scavenging of damaged oxidative organelles, thereby preventing accumulation of toxic oxygen radicals that would cause genome instability. Paradoxically, however, in some cases autophagy can also promote the survival of cancer cells once tumours have developed. This is attributed to the ability of autophagy to promote cell survival under conditions of poor nutrient supply, as often faced by solid tumours and metastasising cancer cells. In addition, autophagy is frequently upregulated in tumours as a response to therapy and may protect tumours against therapy-induced apoptosis. In this review we discuss the mechanisms that link autophagy to tumour suppression and promotion and provide examples of the dual functions of autophagy in cancer.

Keywords: Apoptosis, Autophagy, Beclin 1, Carcinogenesis, Genome instability, Lysosome, PI 3-kinase, Survival, Reactive oxygen species, UVRAG

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(09)00079-9

doi:10.1016/j.molonc.2009.05.007

Molecular Oncology
Volume 3, Issue 4 , Pages 366-375, August 2009